Aura Biosciences, Inc.
AURA • NASDAQ
Aura Biosciences, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Elisabet de los Pinos, with a market cap of $398.2M.
CEOElisabet de los Pinos
Next Earnings
Upcoming earnings announcement for Aura Biosciences, Inc.
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.44
Earnings History
Past 11 earnings reports for Aura Biosciences, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.40Est: -$0.46 | +13.0% | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.47Est: -$0.49 | +4.1% | - | — | 10-Q |
| May 15, 2025 | Q1 2025 | -$0.55 | — | - | — | 10-Q |
| Mar 24, 2025 | Q4 2024 | -$0.52Est: -$0.43 | -20.9% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.42Est: -$0.45 | +6.7% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.41Est: -$0.45 | +8.9% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.40Est: -$0.44 | +9.1% | - | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.50Est: -$1.82 | +72.5% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.48Est: -$0.52 | +7.7% | - | — | — |
| Aug 9, 2023 | Q2 2023 | -$0.48Est: -$0.49 | +2.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.46Est: -$0.54 | +14.8% | - | — | — |